P
POSEIDA THERAPEUTICS INC
NASDAQ: PSTX (Poseida Therapeutics, Inc.)
Kemas kini terakhir: 4 jam lalu3.95
0.34 (9.42%)
| Penutupan Terdahulu | 3.61 |
| Buka | 3.67 |
| Jumlah Dagangan | 723,572 |
| Purata Dagangan (3B) | 504,718 |
| Modal Pasaran | 382,982,528 |
| Harga / Jualan (P/S) | 6.08 |
| Harga / Buku (P/B) | 10.62 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Aug 2024 - 12 Aug 2024 |
| Margin Keuntungan | -40.28% |
| Margin Operasi (TTM) | 27.52% |
| EPS Cair (TTM) | -0.630 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 667.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 94.86% |
| Nisbah Semasa (MRQ) | 3.20 |
| Aliran Tunai Operasi (OCF TTM) | -15.02 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -22.24 M |
| Pulangan Atas Aset (ROA TTM) | -13.11% |
| Pulangan Atas Ekuiti (ROE TTM) | -57.63% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Poseida Therapeutics, Inc. | Bercampur | Bercampur |
AISkor Stockmoo
-1.2
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | -1.5 |
| Osilator Teknikal | 0.0 |
| Purata | -1.17 |
|
Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 27.64% |
| % Dimiliki oleh Institusi | 58.44% |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |